Risultati per: Identificati potenziali bersagli per il cancro al pancreas
Questo è quello che abbiamo trovato per te
Nuove frontiere per la cura del cancro alla prostata
In Sardegna nel 2021 sono stati ricoverati 262 pazienti
Manifesto di Procida, oncologi e manager per la lotta al cancro
Riflettori anche sul problema della sostenibilità economica
Cancro colon-retto, gastrico e pancreatico ereditario: review
Identificato il fattore molecolare scatenante per lo sviluppo del cancro al seno
Radioterapia interna per il tumore al pancreas
Usata per la prima volta in Italia, l’intervento l’11 maggio
Il fegato grasso promuova la diffusione del cancro colon retto
Il 13 maggio la giornata per la prevenzione del cancro orale
In piazze e studi iniziativa di Fondazione Andi, visite gratuite
Da un vaccino a mRna speranze per il tumore al pancreas
Da un vaccino a mRna speranze per il tumore al pancreas
Bene i primi test. Moltiplicate le ricerche in questa direzione
Terapia protonica contro il cancro disponibile a Singapore
Può ridurre gli effetti collaterali rispetto alla radioterapia
L’obesità è un fattore di rischio per il cancro del colon-retto
It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease
Recent advances in single-cell RNA sequencing and bioinformatics have drastically increased our ability to interrogate the cellular composition of traditionally difficult to study organs, such as the pancreas. With the advent of these technologies and approaches, the field has grown, in just a few years, from profiling pancreas disease states to identifying molecular mechanisms of therapy resistance in pancreatic ductal adenocarcinoma, a particularly deadly cancer. Single-cell transcriptomics and related spatial approaches have identified previously undescribed epithelial and stromal cell types and states, how these populations change with disease progression, and potential mechanisms of action which will serve as the basis for designing new therapeutic strategies. Here, we review the recent literature on how single-cell transcriptomic approaches have changed our understanding of pancreas biology and disease progression.
Scoperto come il cancro sfugge al sistema immunitario
Ricerca del team del National Cancer Centre di Singapore
Artificial Pancreas Improved Outcomes in Children With Type 1 Diabetes
Children between the ages of 2 and 6 years who used a closed-loop system to manage their type 1 diabetes spent 12% more time—which translated to about 3 hours—with their blood glucose levels within optimal range compared with those who used either an insulin pump or injections, according to a randomized clinical trial that monitored 102 children for 13 weeks. Hypoglycemia levels were similar between the groups, but 1 case of diabetic ketoacidosis occurred in the closed-loop system group.
Tumore pancreas, combinazione farmaci potenzierebbe chemio
Studio condotto dall’Istituto Pascale di Napoli